Mupirocin Infectopharm

Mupirocin, the active ingredient in Mupirocin Infectopharm, is an antibiotic presented as a topical preparation for nasal use. It treats nasal colonisation by Staphylococcus aureus and helps prevent subsequent staphylococcal infections in at‑risk patients.

GNH USA supplies Mupirocin Infectopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mupirocin is an antibacterial agent used to address bacterial colonisation in the nasal cavity.

- Nasal colonisation of Staphylococcus aureus: reduces bacterial load and helps eradicate carriage. - Prevention of Staphylococcal infections: decreases the risk of infection in individuals prone to staphylococcal disease.

Mupirocin may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation: mild burning or stinging sensation. - Nasal itching: pruritus at the application site. - Dryness of nasal mucosa. - Sneezing or mild rhinorrhoea. - Headache: transient and mild. - Local erythema: redness of the nasal lining.

Serious or Rare Side Effects: - Allergic reaction: rash, urticaria, or angioedema. - Anaphylaxis: severe, potentially life‑threatening hypersensitivity. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Contact dermatitis: persistent inflammation at the site. - Systemic infection: rare bacteremia from compromised mucosa. - Severe mucosal ulceration.

Before using Mupirocin Infectopharm, consider the following safety measures.

- Pregnancy: consult a prescriber; safety data are limited. - Breastfeeding: discuss with a healthcare professional before use. - Known hypersensitivity: avoid if allergic to mupirocin or other topical antibiotics. - Concurrent nasal surgery or trauma: postpone application until healing. - Use only as directed: do not exceed prescribed duration or frequency. - Store at room temperature: keep in the original packaging, protect from moisture and light.

Mupirocin has a low potential for systemic drug interactions, but certain combinations may require attention.

Major Interactions (Avoid): - Concurrent use of other topical antibiotics: may increase risk of bacterial resistance. - Use with nasal decongestants containing vasoconstrictors: can exacerbate local irritation.

Moderate Interactions (Monitor Closely): - Systemic antibiotics: may alter normal flora and affect colonisation dynamics. - Antifungal nasal agents: potential for additive mucosal irritation. - Immunosuppressive therapy: monitor for reduced local antibacterial efficacy. - Chronic steroid nasal sprays: may increase risk of secondary infection. - Use with nasal antihistamines: observe for enhanced dryness.